Patent · US Active

MTKI quinazoline derivatives

US8492377B2 · kind B2 · utility

0Cited by

21References

15Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Alexandra Papanikos · Ekeren, BE
Eddy Jean Edgard Freyne · Rumst, BE
Peter Ten Holte · Beerse, BE
Marc Willems · Beerse, BE
Werner Constant Johan Embrechts · Beerse, BE
Laurence Anne Mevellec · Louviers, FR
Pierre-Henri Storck · Abingdon, GB

Key dates

Filing date	Jul 12, 2007
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Aug 29, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08K5/544
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention concerns the compounds of formulathe N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.